{"id":"https://openalex.org/W2095077765","doi":"https://doi.org/10.1177/0269881113514878","title":"Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union","display_name":"Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union","alternate_titles":[],"publication_year":2013,"publication_date":"2013-12-18","ids":{"openalex":"https://openalex.org/W2095077765","doi":"https://doi.org/10.1177/0269881113514878","mag":"2095077765","pmid":"https://pubmed.ncbi.nlm.nih.gov/24352716"},"language":"en","primary_location":{"id":"doi:10.1177/0269881113514878","doi":"https://doi.org/10.1177/0269881113514878","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881113514878","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2095077765"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103208179","display_name":"James A. Cooper","orcid":"https://orcid.org/0000-0003-3375-5111","observed_orcids":["https://orcid.org/0000-0003-3375-5111"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James A Cooper","raw_affiliation_strings":["GlaxoSmithKline, Brentford, UK","#N# 1GlaxoSmithKline, Brentford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Brentford, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"#N# 1GlaxoSmithKline, Brentford, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014293313","display_name":"Vivian L. Tucker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vivian L Tucker","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, USA","2GlaxoSmithKline, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":[]},{"raw_affiliation_string":"2GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045819737","display_name":"George I. Papakostas","orcid":"https://orcid.org/0000-0002-8886-1416","observed_orcids":["https://orcid.org/0000-0002-8886-1416"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George I Papakostas","raw_affiliation_strings":["The Depression Clinical Research Program, Massachusetts General Hospital, Boston, USA","3The Depression Clinical Research Program, Massachusetts General Hospital, Boston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Depression Clinical Research Program, Massachusetts General Hospital, Boston, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"3The Depression Clinical Research Program, Massachusetts General Hospital, Boston, USA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":3.5345,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.9207832,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"28","issue":"2","first_page":"118","last_page":"124"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.9890000224113464},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9900000095367432},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.675000011920929},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.734000027179718},{"id":"https://openalex.org/keywords/hypersomnia","display_name":"hypersomnia","score":0.9480000138282776},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9810000061988831},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":1.0},{"id":"https://openalex.org/keywords/escitalopram","display_name":"escitalopram","score":0.9869999885559082},{"id":"https://openalex.org/keywords/antidepressant-comparison","display_name":"antidepressant comparison","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.932462215423584},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.6870532631874084},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.5965660214424133},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.5464041829109192},{"id":"https://openalex.org/C2779583969","wikidata":"https://www.wikidata.org/wiki/Q423757","display_name":"Escitalopram","level":4,"score":0.5208231210708618},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.5197679400444031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4830349385738373},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4694520831108093},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4583451449871063},{"id":"https://openalex.org/C2779034229","wikidata":"https://www.wikidata.org/wiki/Q1077823","display_name":"Somnolence","level":3,"score":0.4520624876022339},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.44193384051322937},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.3535107970237732},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3496708869934082},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2563428282737732},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012893","descriptor_name":"Sleep Wake Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881113514878","doi":"https://doi.org/10.1177/0269881113514878","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881113514878","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:24352716","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24352716","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W100052691","https://openalex.org/W100865822","https://openalex.org/W203770306","https://openalex.org/W1680855902","https://openalex.org/W1966942082","https://openalex.org/W1969633915","https://openalex.org/W1976348067","https://openalex.org/W1981274951","https://openalex.org/W1982880546","https://openalex.org/W1983601360","https://openalex.org/W1987685542","https://openalex.org/W1989364623","https://openalex.org/W1991296006","https://openalex.org/W1991497633","https://openalex.org/W2008979600","https://openalex.org/W2009578329","https://openalex.org/W2018434620","https://openalex.org/W2024985387","https://openalex.org/W2041144155","https://openalex.org/W2041924199","https://openalex.org/W2047397850","https://openalex.org/W2056454671","https://openalex.org/W2062684328","https://openalex.org/W2082205780","https://openalex.org/W2083048235","https://openalex.org/W2088302707","https://openalex.org/W2089694151","https://openalex.org/W2096527989","https://openalex.org/W2096924058","https://openalex.org/W2107061908","https://openalex.org/W2115714588","https://openalex.org/W2116580967","https://openalex.org/W2122011624","https://openalex.org/W2123285978","https://openalex.org/W2126616088","https://openalex.org/W2133433402","https://openalex.org/W2145911019","https://openalex.org/W2150840378","https://openalex.org/W2159011576","https://openalex.org/W2159835986","https://openalex.org/W2165700518","https://openalex.org/W2167845443","https://openalex.org/W2170691050","https://openalex.org/W2195753060","https://openalex.org/W2201061284","https://openalex.org/W2201946268","https://openalex.org/W2413135665","https://openalex.org/W2427096510","https://openalex.org/W4234076493","https://openalex.org/W4249913657"],"related_works":["https://openalex.org/W2062684328","https://openalex.org/W2047433176","https://openalex.org/W2044865959","https://openalex.org/W4236465344","https://openalex.org/W100865822","https://openalex.org/W2089694151","https://openalex.org/W2120851716","https://openalex.org/W1974341237","https://openalex.org/W7203836825","https://openalex.org/W2024159452"],"abstract_inverted_index":{"Unlike":[0],"selective":[1],"serotonin":[2],"reuptake":[3,16],"inhibitors":[4],"(SSRIs),":[5],"bupropion":[6,62],"may":[7,196],"be":[8],"classified":[9],"as":[10,80,99,106],"a":[11,18],"dual":[12],"noradrenaline":[13],"and":[14,29,74,95,104,112,145,166,181,206],"dopamine":[15],"inhibitor,":[17],"difference":[19],"with":[20,40,63],"potential":[21],"implications":[22],"for":[23,69,178,184],"the":[24,54,70,81,86,190,202],"treatment":[25,188],"of":[26,38,59,72,83,85,110,137,193,204],"residual":[27,135],"sleepiness":[28,73,138,164,179,205],"fatigue":[30,97,146,167,185,207],"in":[31,163,201,208],"major":[32],"depressive":[33],"disorder":[34],"(MDD).":[35],"Post-hoc":[36],"analysis":[37],"subjects":[39,114],"remitted":[41,209],"MDD":[42,210],"was":[43,78],"performed":[44],"on":[45],"data":[46],"pooled":[47],"from":[48,161,175],"six":[49],"double-blind,":[50],"randomized":[51],"trials":[52],"comparing":[53],"European":[55],"Union":[56],"(EU)-approved":[57],"dose":[58,192],"\u2264300":[60,194],"mg/day":[61,195],"SSRIs":[64,200],"(sertraline,":[65],"paroxetine":[66],"or":[67],"escitalopram)":[68],"resolution":[71,203],"fatigue.":[75],"Hypersomnia":[76],"score":[77,98],"defined":[79],"sum":[82],"scores":[84,168],"Hamilton":[87],"Depression":[88],"Rating":[89],"Scale":[90],"(HDRS)":[91],"items":[92],"22,":[93],"23,":[94],"24;":[96],"HDRS":[100],"item":[101],"13":[102],"score;":[103],"remission":[105,116],"HDRS-17\u22647.":[107],"Similar":[108],"proportions":[109],"bupropion-":[111],"SSRI-treated":[113],"achieved":[115],"at":[117,170,189],"study":[118],"endpoint":[119],"(169/343,":[120],"49.3%":[121],"vs":[122,141,149],"324/656,":[123],"49.4%;":[124],"last":[125],"observation":[126],"carried":[127],"forward":[128],"(LOCF),":[129],"p=0.45).":[130],"Fewer":[131],"bupropion-treated":[132],"remitters":[133,154],"had":[134],"symptoms":[136],"(32/169,":[139],"18.9%":[140],"104/324,":[142],"32.1%;":[143],"p<0.01)":[144],"(33/169,":[147],"19.5%":[148],"98/324,":[150],"30.2%;":[151],"p<0.05).":[152],"Bupropion-treated":[153],"also":[155],"showed":[156],"greater":[157],"improvement":[158],"(mean":[159],"change":[160],"baseline)":[162],"(p<0.05)":[165],"(p<0.01)":[169,180],"endpoint:":[171],"benefits":[172],"were":[173],"evident":[174],"week":[176,182],"2":[177],"4":[183],"(p<0.01).":[186],"Bupropion":[187],"EU-approved":[191],"offer":[197],"advantages":[198],"over":[199],"patients.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2095077765","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
